Scientists test First-Ever vaccine to protect pregnant women from malaria
NCT ID NCT02658253
Summary
This early-stage study tested the safety of a new vaccine designed to protect pregnant women from malaria. The trial involved 68 healthy adult women in France and Burkina Faso who received different doses of the experimental vaccine. Researchers monitored participants for side effects and measured how their immune systems responded to the vaccine.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CIC 1417
Paris, 75679, France
-
CNRFP
Ouagadougou, BP 2208, Burkina Faso
Conditions
Explore the condition pages connected to this study.